Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the risk of liver fibrosis (= scarring of the liver), liver cirrhosis (= shrunken liver), a liver tumor or death. So far there is no recognized treatment option for this disease. However, there is evidence that a lifestyle change based on a reduced carbohydrate diet, more exercise and a significant weight loss that can improve NASH.
Outpatients with NASH will be included into this lifestyle intervention study. Patients will get nutritional advices and a formula diet for 12 weeks. Clinical visits will take place at baseline, after 4, 12 and after 52 weeks.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lifestyle intervention | Experimental | Nutrition advices and formula diet |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Formula diet | Dietary Supplement | Formula diet for 12 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| degree of steatosis | degree of steatosis in decibels per meter (dB/m) measured by Controlled Attenuation Parameter (CAP) estimation | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| degree of steatosis | degree of steatosis in decibels per meter (dB/m) measured by Controlled Attenuation Parameter (CAP) estimation | 52 weeks |
| degree of fibrosis | degree of fibrosis in meter per second (m/s) measured by Acoustic Radiation Force Impulse (ARFI) elastography |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stephan Martin, MD | West-German Centre of Diabetes and Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Düsseldorf Catholic Hospital Group | Düsseldorf | 40591 | Germany | |||
| Praxis Prof. Erhardt |
Not provided
| ID | Term |
|---|---|
| D065626 | Non-alcoholic Fatty Liver Disease |
| D050177 | Overweight |
| D005234 | Fatty Liver |
| ID | Term |
|---|---|
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D005526 | Food, Formulated |
| ID | Term |
|---|---|
| D019648 | Foods, Specialized |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
Not provided
Not provided
Lifestyle intervention including formula diet
Not provided
Not provided
Not provided
Not provided
| 12 weeks and 52 weeks |
| fat mass | fatt mass in kilogram (kg) measured by Bioelectrical Impedance Analysis (BIA) | 12 weeks and 52 weeks |
| Glutamate Pyruvate Transaminase (GPT) | Glutamate Pyruvate Transaminase in units/litre (U/L) | 12 weeks and 52 weeks |
| Gamma-glutamyltransferase (GGT) | Gamma-glutamyltransferase in units/litre (U/L) | 12 weeks and 52 weeks |
| insulin | insulin in micro units per millilitre (µU/ml) | 12 weeks and 52 weeks |
| Wuppertal |
| 42283 |
| Germany |
| D009750 |
| Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D019602 |
| Food and Beverages |